Vardenafil Orodispersible Tablet (ODT) Versus Placebo in Males With Erectile Dysfunction, 50% of Whom Are to be 65 Years or Older.

PHASE3CompletedINTERVENTIONAL
Enrollment

339

Participants

Timeline

Start Date

April 30, 2008

Primary Completion Date

February 28, 2009

Study Completion Date

February 28, 2009

Conditions
Erectile Dysfunction
Interventions
DRUG

Vardenafil ODT (STAXYN, BAY38-9456)

Subjects will receive 12 weeks of PRN (on demand) treatment with Vardenafil 10 mg orodispersible tablet (ODT)

DRUG

Placebo

Subjects will receive 12 weeks of PRN (on demand) treatment with matching placebo tablet

Trial Locations (40)

2022

Sydney Men's Health, Bondi Junction

2065

Berry Road Medical Centre, St Leonards

3144

Cabrini Medical Centre, Melbourne

5000

South Terrace Urology, Adelaide

6009

Queen Elizabeth II Medical Centre, Nedlands

Perth Human Sexuality Centre, Perth

10029

Mount Sinai Medical Center, New York

11021

Office of Dr. Bruce Gilbert, MD, Great Neck

14000

Asociación Mexicana para la Salud Sexual A. C., México D. F.

19056

Family Medical Associates, Levittown

19401

Pearl Clinical Research, Norristown

32223

Jacksonville Impotence Treatment Center, Jacksonville

33024

University Clinical Research, Inc., Pembroke Pines

33180

South Florida Medical Research, Aventura

43220

Columbus Urology Research, LLC, Columbus

45040

Consultorio Dr. Rodríguez Rivera, Guadalajara

70112

Tulane Medical Center, New Orleans

85023

Arizona Research Center, Inc., Phoenix

85050

Tatum Highlands Medical Associates, PLLC, Phoenix

85203

Mesa Family Medical Center, Mesa

85213

Desert Clinical Research, Mesa

85224

East Valley Family Physicians, PLC, Chandler

85283

Fiel Family & Sports Medicine, PC, Tempe

91950

Synergy Clinical Research Center, National City

92103

San Diego Uro-Research, San Diego

92120

San Diego Clinical Trials, San Diego

97001

Centro Médico de las Américas, Mérida

99206

Office of Dr. Roger Fincher, MD, Spokane

92618-3603

Irvine Center for Clinical Research, Irvine

45212-2787

The Urology Group, Cincinnati

N6A 4V2

St.Joseph's Health Care-London, London

L6H 3P1

The Male Health Centres, Oakville

M4C 5T2

Office of Dr. Rajiv Singal, MD, Toronto

M4N 3M5

Sunnybrook Health Sciences Centre, Toronto

G7H 4A3

Clinique d'Urologie du Saguenay, Chicoutimi

J4V 2H3

Urology South Shore Research, Greenfield Park

H2X 1N8

Centre de Recherche en Sante Sexuelle du Quebec, Montreal

H3T 1E2

Sir Mortimer B. Davis Jewish General Hospital, Montreal

06700

Hospital Dalinde, México, D. F.

Hospital Santa Fé, México, D. F.

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

GlaxoSmithKline

INDUSTRY

collaborator

Schering-Plough

INDUSTRY

lead

Bayer

INDUSTRY

NCT00655629 - Vardenafil Orodispersible Tablet (ODT) Versus Placebo in Males With Erectile Dysfunction, 50% of Whom Are to be 65 Years or Older. | Biotech Hunter | Biotech Hunter